ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,045Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1677

$1.29M Total Retail Price of All Prescriptions

Rank: 31 out of 1677

814 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 814 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

40% of this provider’s 814 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 21,568 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,681 1,074 S3 1 4
FUROSEMIDE 1,014 789 2 8
LEVOTHYROXINE SODIUM 914 751 3 5
SIMVASTATIN 896 649 4 1
AMLODIPINE BESYLATE 849 727 5 2
OMEPRAZOLE 721 495 6 6
LISINOPRIL 632 451 7 3
POTASSIUM CHLORIDE 625 491 8 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 553 400 9 17
ATENOLOL 520 387 10 21
METOPROLOL TARTRATE 492 440 11 12
METOPROLOL SUCCINATE 489 338 12 23
FAMOTIDINE 464 338 13 41
CITALOPRAM HBR 454 317 14 22
WARFARIN SODIUM 403 356 15 24
ZOLPIDEM TARTRATE 392 257 16 15
HYDROCHLOROTHIAZIDE 379 311 17 9
LOSARTAN-HYDROCHLOROTHIAZIDE 373 289 18 42
GABAPENTIN 336 249 19 11
METFORMIN HCL 311 198 20 7
NEXIUM 304 217 21 19
DONEPEZIL HCL 291 291 22 30
PRAVASTATIN SODIUM 288 233 23 10
GLYBURIDE-METFORMIN HCL 268 188 R 24 121
ATORVASTATIN CALCIUM 264 196 25 13
FLUTICASONE PROPIONATE 260 188 26 29
DIOVAN HCT 250 207 27 66
KLOR-CON 10 247 176 28 106
MELOXICAM 243 180 29 27
ENDOCET 231 62 S2 30 114
LANTUS 228 153 31 44
INSULIN SYRINGE 225 147 32 72
QUETIAPINE FUMARATE 217 170 33 77
ALLOPURINOL 212 142 34 31
TAMSULOSIN HCL 207 189 35 34
METHYLPREDNISOLONE 206 140 36 145
NIFEDIPINE ER 206 160 36 98
PROAIR HFA 203 138 38 50
PAROXETINE HCL 202 129 39 67
CARVEDILOL 202 163 39 20
GLIMEPIRIDE 201 165 41 33
CLOPIDOGREL 191 143 42 32
AZITHROMYCIN 189 128 43 38
CIPROFLOXACIN HCL 188 135 44 57
BISOPROLOL-HYDROCHLOROTHIAZIDE 178 166 45 107
SERTRALINE HCL 170 142 46 26
PREDNISONE 166 113 47 40
CYCLOBENZAPRINE HCL 165 100 R 48 52
CRESTOR 165 124 48 28
TRAMADOL HCL 157 90 50 16
DIGOXIN 155 128 51 71
COLCRYS 140 89 52 141
PLAVIX 128 102 53 47
LOSARTAN POTASSIUM 123 83 54 25
RISPERIDONE 122 87 55 60
SPIRONOLACTONE 121 74 56 88
PROMETHAZINE HCL 118 79 R 57 64
LEVEMIR 115 105 58 157
DIOVAN 113 82 59 45
METOCLOPRAMIDE HCL 110 92 60 124
NAMENDA 109 109 61 39
METOLAZONE 109 81 61 205
MIRTAZAPINE 107 83 63 62
CARISOPRODOL 104 34 R 64 68
POLYETHYLENE GLYCOL 3350 104 90 64 76
IBUPROFEN 102 64 66 83
OXYCODONE HCL-ACETAMINOPHEN 102 58 S2 66 115
FENTANYL 101 73 S2 68 103
HYDRALAZINE HCL 100 83 69 69
AMLODIPINE BESYLATE-BENAZEPRIL 98 59 70 59
ADVAIR DISKUS 96 69 71 54
KLOR-CON M20 93 75 72 65
AMOX TR-POTASSIUM CLAVULANATE 91 65 73 126
VENLAFAXINE HCL ER 90 67 74 92
ESCITALOPRAM OXALATE 87 61 75 80
DETROL LA 86 65 76 185
SEROQUEL 86 69 76 151
ISOSORBIDE MONONITRATE ER 86 76 76 73
LYRICA 85 64 79 81
TRIAMCINOLONE ACETONIDE 85 69 79 134
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 61 81 85
CEPHALEXIN 84 71 81 99
SPIRIVA 82 48 83 74
CLONIDINE HCL 82 50 83 36
DICLOFENAC SODIUM 81 64 85 95
NYSTATIN-TRIAMCINOLONE 80 63 86 264
GLIPIZIDE ER 79 79 87 78
AMITRIPTYLINE HCL 77 57 R 88 63
AMOXICILLIN 75 43 89 94
JANUVIA 74 37 90 70
NOVOLIN R 71 66 91 133
CELEBREX 71 66 91 102
MEGESTROL ACETATE 71 64 R 91 182
LEVOFLOXACIN 70 47 94 84
FINASTERIDE 69 69 95 130
FLUCONAZOLE 69 34 95 127
MORPHINE SULFATE ER 68 21 S2 97 140
PHENYTOIN SODIUM EXTENDED 68 61 97 112
LEVETIRACETAM 67 57 99 116
PEN NEEDLE 66 37 100 164
NIFEDIAC CC 64 36 101 302
PREMARIN 63 31 R 102 109
VENTOLIN HFA 62 31 103 89
ZETIA 62 45 103 75
LIPITOR 62 49 103 101
RANITIDINE HCL 61 42 106 18
PANTOPRAZOLE SODIUM 61 53 106 46
DOXYCYCLINE HYCLATE 60 38 108 96
METFORMIN HCL ER 59 47 109 51
OXYCODONE HCL 55 27 S2 110 91
HYDROXYZINE HCL 54 36 R 111 148
MECLIZINE HCL 54 52 111 110
LANTUS SOLOSTAR 53 28 113 132
NOVOLOG 52 30 114 117
LIDOCAINE HCL VISCOUS 50 22 115 485
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.